MANE
Veradermics, Incorporated
Stock
$116.76−0.46 (−0.39%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 |
|---|---|---|---|
| Cash and short-term investments | $820M | $142M | $53M |
| Current assets | $825M | $152M | $56M |
| Total assets | $826M | $153M | $56M |
| Current liabilities | $12M | $9.2M | $4.7M |
| Total liabilities | $12M | $9.2M | $4.7M |
| Shareholders' equity | $814M | −$121M | −$48M |
| Shares outstanding | 41.8M | 37.3M | — |
| Current ratio | 70.53 | 16.66 | 11.77 |